Press Release Hub logo
  • Submit a Release
  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Cambrex Expands Peptide Manufacturing Capabilities in Waltham, Massachusetts

Contributed by: PR Newswire

Images

PR Newswire associated0
PR Newswire associated1

Tags

Cambrex-Manufacturing

More Like This

PR Newswire associated0

Cambrex Announces New Liquid-Phase Peptide Synthesis Manufacturing Technology

PR Newswire associated0

Snapdragon Chemistry, a Cambrex Company, Recognized with CPhI Pharma Award for API Development

PR Newswire associated0

Cambrex Completes $38 Million Capacity Expansion in High Point, North Carolina

PR Newswire associated0

Cambrex Announces Sale of Drug Product Business Unit

PR Newswire associated0

Cambrex Nears Completion of 5-year, $100-Million-Dollar Investment Plan, One Year Ahead of Schedule

PR Newswire associated0

Cambrex Announces Strategic Agreement with Lilly to Support Biotech Collaborator Manufacturing

Business Wire logo

Asymchem’s Fully Automated Peptide Production Lines Set New Benchmarks as Large-Scale Capacity Continues to Grow

PR Newswire associated0

CordenPharma Expands Peptide Platform with more than 500 Million Euro Greenfield Facility Construction in the Basel Region of Switzerland

Pages

  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Press Release Hub

  • Our Services
  • Submit a Release

Websites

  • PA Media Group
  • PA Mediapoint
  • Distribution Packages

© PA Media Group. 2025

Terms of Use

Privacy Policy

Contact Us